Informa Australia is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Register Your Interest


Bio Connections Australia

Optimising Clinical Trials | Commercialising Great Science | Partnering for Growth

18 November 2021 | Rydges Melbourne

We are excited to be moving back to face-to-face events but will continue to offer the option to attend the event virtually

Register Your Interest


Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization.

2020 saw significant disruption to the drug development and clinical trials landscape in Australia and around the world. Australia’s response was remarkable in its ability to respond to the challenges and capture opportunities. How we maintain that momentum and build upon this is an important theme for discussion in 2021.

Ongoing work is needed to drive Australia to become globally competitive in novel therapeutics and create better pathways for companies to translate their great research into commercial products. From effective early partnering to funding plans for translation and commercialisation – this event is a critical opportunity for dialogue and debate between key stakeholders.

Australia is now well known as a leading destination for early phase clinical trials. The next step is to ensure we maintain the efficiencies and innovations adopted during the pandemic and build upon them. What are the innovative models which can be adopted and sustained? What are the opportunities with new tech and devices within clinical trials and what are the regulatory considerations?

Our communities are keen to reconnect, network, and learn more than ever after months of disruption. We are excited to be moving back to in-person events but will continue to offer the option to attend the event virtually.

Key topics to be covered in 2021:

  • Best practice examples in maturing assets and taking discoveries into clinic the right way
  • Emerging technology and remote monitoring in clinical trials
  • Devices in clinical trials
  • Manufacturing capabilities in Australia – exploring what’s needed and where opportunities lie
  • Creating efficiencies – models to bring the right patient to the right trial and increasing recruitment to studies
  • Learnings from the efficiencies achieved with covid vaccine pipeline – can we apply this to other therapeutics?
  • Trials in primary heath and GP Health network settings
  • Virtual trials and teletrials in Australia
  • Home based trials and hospital in the home
  • The clinical trials governance framework in Australia
  • Sustainability into clinical trial units in rural and regional areas
  • The post-covid investment landscape
  • Breakthrough Victoria Fund to boost research & innovation
  • Clinical Trial Diversity and Inclusion


The Hon John Brumby AO

Chancellor, La Trobe University, Chairman and Director, BioCurate, Chair, Breakthrough Victoria Fund

David Thomas FRACP

Phd, Head, Genomic Cancer Medicine, Garvan Institute of Medical Research, Director, The Kinghorn Cancer Centre & Chief Executive Officer, Omico: Australian Genomic Cancer Medicine Centre

Dr Anand Gautam

Executive Director & Emerging Science Lead, Emerging Science & Innovation, Asia & APAC (Australia & New Zealand), Pfizer Worldwide R&D

Suhit Anantula

Director of Technology Strategy and Policy, Department of Premier and Cabinet, Government of South Australia

Jefferson Harcourt

Executive Chairman, Grey Innovation Group

Dr Mark Ashton

Executive Director, IP Commercialisation, UniQuest

Associate Professor Tam C. Nguyen

Deputy Director of Research, St Vincent's Hospital Melbourne

Ben Constable

Managing Director, Australia, Lumira Ventures

Anita van der Meer

Manager, clinicaltrialsNSW | Office for Health and Medical Research, NSW Ministry of Health

Dr Tina Soulis

Founder and Director, Alithia Life Sciences

Jai Rautela

Co-Founder & CEO, oNKo-innate

Linda Peterson

Chief Operating Officer and Company Secretary, BioCurate Pty Ltd

Dr Deborah Rathjen

CEO, Carina Biotech

Gail Dawson

Director, Clinical Pharmacology  & Translational Development Operations, CSL

Dr John Patava

Chief Operating Officer, AUM Biosciences

Megan Ford

Executive Director Clinical Trials, Ingham Institute, South Western Sydney Local Health District

Jerneen Williams

Early Phase Clinical Trial Manager, Bellberry Limited

Dr. Russell Tait

CEO, PolyActiva Pty. Ltd

Max Rossetto

GM Business Development, Luina Bio

Kevin Wightman

Senior Director of Business and Corporate Development, Asia Pacific, Illingworth Research Group a Syneos Health Company

Professor Ian Alexander

Clinical Geneticist, FAHMS, Director Laboratory Research and Senior Staff Specialist, The Children’s Hospital at Westmead, Professor in Paediatrics and Molecular Medicine, University of Sydney & Head of the Gene Therapy Research Unit, a joint initiative of Children’s Medical Research Institute and The Children’s Hospital at Westmead (CHW)

Dr Ric DeGaris

Interim CEO / Head, Clinical Operations, Neuroscience Trials Australia

Ben Edwards

Chief Strategy Officer, Avance Clinical

Professor Sally McArthur

Co-Director, MedTechVic & Director, Manufacturing Futures Research Institute

Mark Sullivan

Founder and Managing Director, Medicines Development for Global Health

Sanji Kanagalingam

CEO, WeGuide & MD, Curve Group

Bio Palooza is back for 2021!

We are delighted to announce the event highlight Bio Palooza Dinner will be returning for the 2021 edition of Bio Connections Australia. Don’t miss out on this intimate get together and key networking opportunity to further discuss and connect following the conference with your fellow delegates and speakers in this informal setting.

Register Your Interest

Health & Safety Commitments

When you join our event, you can expect to see that health and safety is a priority, and that a range of measures are in place to ensure everyone involved is able to enjoy a safe, hygienic, productive and high-quality organised event experience.

All Informa events will be run according to official government and local authority guidance in the first instance, as well as any venue or location-specific regulations. In addition, Informa Australia will follow some key health and safety priority commitments as part of “Informa AllSecure“.

Full vaccination against Covid-19 is required for all in-person attendees.

IMPORTANT: For more information on Informa’s Vaccination requirement for all in-person attendees, our Event Health & Safety measures in place and Conditions of entry, click here.


Our Commitment to Sustainability

In Australia, we are committed to running our events in an environmentally and socially responsible way. Across Informa Connect we are focusing on the short and long-term sustainability impacts we have on customers and colleagues alongside the communities we work in.

We recognise that it’s not just about the way we produce our events and products but recognising that we have a role to play in providing a space to work in partnership together with our markets to inspire the sustainable development of the industries we serve.

To read more on our latest sustainability reports and Faster Forward initiatives – click here.

when & where

18 Nov 2021

Rydges Melbourne
186 Exhibition St,
Melbourne VIC 3000
(03) 9662 0511


Still have a question?

Frankie Brewer
Conference Manager
+61 2 9080 4015

Danielle Newman
Senior Business Development Manager
+61 (2) 9080 4318

Get all the latest on Informa news and events

Informa Connect Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more

COVID-19  Cancellation  Policy
Read  Policy  Terms